Nephrology News

The risk of developing nephrogenic systemic fibrosis was low with the use of gadolinium-based contrast agents for MRI in patients with CKD, according to a recently published study.

Researchers of a published study found a high prevalence of both depressive symptoms and dietary non-adherence in patients on hemodialysis and further observed a significant association between symptoms of depression and likelihood of not adhering to dietary recommendations.

WASHINGTON — Data presented at ASN Kidney Week indicated the incidence of acute kidney injury is higher for non-critically ill hospitalized pediatric patients than indicated by previous research.

Researchers of a published study found patients with obesity who underwent robotic-assisted kidney transplantation had comparable patient and graft survival to those without obesity who underwent open transplant during the same time period. The rate of surgical complications was also low.

WASHINGTON — A speaker at ASN Kidney Week provided what she called “a different perspective on hospitalization risk,” telling the audience that considering psychosocial factors may help with interventions aimed at reducing the risk of hospitalization for patients on hemodialysis.

WASHINGTON — The rate of women hospitalized for acute kidney injury during pregnancy has increased in recent years and is associated with high rates of in-patient mortality, according to research presented at ASN Kidney Week. The risk for pregnancy-related AKI is greatest for women with diabetes, according to the study.

Recently published findings determined that PD use increased after the implementation of the 2011 Medicare prospective payment system for dialysis, yet specific patient characteristics were associated with the likelihood of utilization.

WASHINGTON — Data presented at ASN Kidney Week suggested higher dietary protein intake is associated with increased risk for all-cause mortality and ESRD in patients with chronic kidney disease, with researchers also observing a decline in dietary protein intake with progressive loss of kidney function.

WASHINGTON — Patiromer was effective in controlling serum potassium in hyperkalemic patients with diabetes and advanced kidney disease on renin-angiotensin-aldosterone system inhibitors, according to research presented here.

WASHINGTON — Results from the phase 3 OLYMPUS trial presented here show the investigational hypoxia-inducible factor prolyl hydroxylase inhibitor drug roxadustat significantly increased hemoglobin levels in patients with anemia and chronic kidney disease compared to those treated with placebo.